75F40125F19007↗

Booz Allen Hamilton Inc received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $477.8K obligated so far for support- management: other. Its period of performance ended 2026-08-01.

Key facts · data as of Oct 25, 2026

Recipient
Booz Allen Hamilton Inc
Awarding agency
Food and Drug Administration (Department of Health and Human Services)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Obligated to date
$477.8K
Potential value
$477.8K
Ends
2026-08-01

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award 75F40125F19007, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75F40125F19007_7524_75F40124A00001_7524

USE OF PATIENT EXPERIENCE DATA IN REGULATORY DECISION MAKING

Bpa Call · Food and Drug Administration · to Booz Allen Hamilton Inc (UEI JCBMLGPE6Z71) · data as of 2026-10-25

Obligated to date$477.8K2 actions
Current value$477.8Kwith options exercised
Period2025-08-25 → 2026-08-01current end date

Up for re-bid: ends 2026-08-01. Recompete brief → · Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ ↗

What it is

Product or service
Support- Management: Other (PSC R799)
Industry
Administrative Management and General Management Consulting Services (NAICS 541611)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Competition
Full and open competition
Pricing
Firm fixed price
How it was bought
Blanket purchase agreement (BPA) · under 75F40124A00001
Solicitation
75F40125Q00267
Where the work is
Fairfax, VA · district VA-11

Obligations by fiscal year

FY2025$477.8K
FY2026$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2025-08-25. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-06-26P00001Administrative change$0EO 14398 USE OF PATIENT EXPERIENCE DATA IN REGULATORY DECISION MAKING - NO COST EXTENSION
2025-08-250$477.8KUSE OF PATIENT EXPERIENCE DATA IN REGULATORY DECISION MAKING

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗